Lau Associates’s AbbVie ABBV Stock Holding History

Lau Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,251	Closed	-$473K	–	95
2019 Q3	$473K	Buy	6,251 +189	+3%	+$13K	0.25%	66
2019 Q2	$441K	Sell	6,062 -814	-12%	-$64K	0.21%	69
2019 Q1	$554K	Hold	6,876	–	–	0.29%	61
2018 Q4	$634K	Buy	6,876 +322	+5%	+$28.3K	0.35%	64
2018 Q3	$620K	Hold	6,554	–	–	0.35%	59
2018 Q2	$607K	Hold	6,554	–	–	0.42%	49
2018 Q1	$620K	Sell	6,554 -3,859	-37%	-$424K	0.48%	51
2017 Q4	$1.01M	Sell	10,413 -2,666	-20%	-$251K	0.78%	43
2017 Q3	$1.16M	Buy	13,079 +1,000	+8%	+$76.1K	0.9%	42
2017 Q2	$876K	Sell	12,079 -1,164	-9%	-$78.3K	0.7%	49
2017 Q1	$863K	Buy	13,243 +7,370	+125%	+$463K	0.77%	49
2016 Q4	$368K	Hold	5,873	–	–	0.37%	57
2016 Q3	$370K	Sell	5,873 -400	-6%	-$25.9K	0.38%	57
2016 Q2	$388K	Hold	6,273	–	–	0.41%	57
2016 Q1	$358K	Hold	6,273	–	–	0.37%	57
2015 Q4	$372K	Hold	6,273	–	–	0.4%	52
2015 Q3	$341K	Hold	6,273	–	–	0.4%	52
2015 Q2	$421K	Hold	6,273	–	–	0.41%	49
2015 Q1	$367K	Hold	6,273	–	–	0.35%	53
2014 Q4	$411K	Hold	6,273	–	–	0.37%	53
2014 Q3	$362K	Sell	6,273 -1,500	-19%	-$83.3K	0.33%	55
2014 Q2	$439K	Sell	7,773 -400	-5%	-$21K	0.4%	47
2014 Q1	$420K	Hold	8,173	–	–	0.37%	48
2013 Q4	$432K	Hold	8,173	–	–	0.38%	47
2013 Q3	$366K	Hold	8,173	–	–	0.3%	46
2013 Q2	$338K	Buy	+8,173	New	+$357K	0.29%	51

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Lau Associates's ABBV Position: Q4 2019 in Review

Lau Associates sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 6,251 shares — an estimated $473K sold.

Lau Associates first reported a position in ABBV in Q2 2013 and held it in 26 quarters. The position peaked at $1.16M in Q3 2017. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

Lau Associates reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
Lau Associates sold 6,251 AbbVie shares in Q4 2019, an estimated $473K.
Lau Associates first reported a position in AbbVie in Q2 2013 and held it in 26 quarters.
Lau Associates's AbbVie position peaked at $1.16M in Q3 2017.
2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.